Efficacy and Safety of mFOLFOX-6 in Advanced Gastric Cancer: A Prospective Observational Study by Amrith B. Patel, Varun Goel, Srujana Joga, V.P.B. Koyyala, Sumit Goyal, Dinesh C. Doval, Ullas Batra, Vineet Talwar

Subjects: Get full text

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301) by Keisuke Miwa, Eiji Oki, Masanobu Enomoto, Keisuke Ihara, Koji Ando, Fumihiko Fujita, Masahiro Tominaga, Shinichiro Mori, Goro Nakayama, Mototsugu Shimokawa, Hiroshi Saeki, Hideo Baba, Masaki Mori, Yoshito Akagi

Subjects: Get full text

Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab by Mototsugu Matsunaga, Keisuke Miwa, Yosuke Oka, Sachiko Nagasu, Takahiko Sakaue, Masaru Fukahori, Tomoyuki Ushijima, Yoshito Akagi

Subjects: Get full text

mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma by Mototsugu Matsunaga, Keisuke Miwa, Yosuke Oka, Sachiko Nagasu, Takahiko Sakaue, Masaru Fukahori, Tomoyuki Ushijima, Yoshito Akagi

Subjects: Get full text

Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) p... by Taku Naiki, Toshiki Etani, Aya Naiki-Ito, Kana Fujii, Ryosuke Ando, Keitaro Iida, Takashi Nagai, Yosuke Sugiyama, Motoo Nakagawa, Noriyasu Kawai, Takahiro Yasui

Subjects: Get full text

Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report by Masamichi Yamaura, Takeshi Yamada, Rei Watanabe, Hitomi Kawai, Suguru Hirose, Hiroki Tajima, Masashi Sato, Yuichi Uchida, Daisuke Suganuma, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Ichinosuke Hyodo

Subjects: Get full text

Long-term stable disease with mFOLFOX6 chemotherapy plus cetuximab for bone marrow metastasis from rectal cancer: A case report by Xiumei Fan, Fang Li, Chong Xiao, Chong Xiao, Yi Cai, Fengming You, Fengming You

Subjects: Get full text

mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial by Kyung-Ha Lee, In Jun Yang, Gi Won Ha, Jaeim Lee, Youn Young Park, Suk Hwan Lee, Jong Min Lee, Jung Hoon Bae, Eun Jung Park, Hyungjin Kim, Keun Young Kim, Sanghyung An, Ik Yong Kim, Ji Yeon Kim

Subjects: Get full text

Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer by Z.A. Wainberg, P.C. Enzinger, S. Qin, K. Yamaguchi, J. Wang, X. Zhou, A. Gnanasakthy, K. Taylor, A. Yusuf, I. Majer, A. Jamotte, Y.-K. Kang

Subjects: Get full text